Monograph
M09AX01 - Hyaluronic Acid |
Not porphyrinogenic |
NP |
Rationale
Glycosaminoglycan. Non-CYP dependent metabolism.
Chemical description
Glycosaminoglycan used in intra- articular injection for treatment of kneejoint arthrosis. Eliminated from the joint fluid within 48 hours and broken down in the liver as well as in the lymphglands.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Belgium
Hyalgan · Hyalgan 20 mg/2 ml sol. inj. i.artic. ser. préremplieUnited Kingdom
Hyalgan · Hyalgan 20mg/2ml solution for injection pre-filled syringesDenmark
HyalganPoland
Hyalgan · Hyaluroprol · Natrii hyaluronas MedezinLuxembourg
HYALGANFinland
HyalganLatvia
HyalganSerbia
Hyalgan · Hyalgan®
© NAPOS 2024